Vital signs: Racial disparities in breast cancer severity - United States, 2005-2009

Morbidity and Mortality Weekly Report

Volumn 61, Issue 45, 2012, Pages 922-926

  Cronin, Kathleen A ^a   Richardson, Lisa C ^b   Henley, S Jane ^b   Miller, Jacqueline W ^b   Thomas, Cheryll C ^b   White, Arica ^b   Plescia, Marcus ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CAUCASIAN; EARLY DIAGNOSIS; ETHNOLOGY; FEMALE; HEALTH DISPARITY; HUMAN; INCIDENCE; MIDDLE AGED; MORTALITY; NEGRO; PATHOLOGY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STATISTICS; SURVIVAL; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84870912839     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012;118:2338-2366.
2. Berry DA, Cronin KA, Plevritis SK, et al; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92.
3. Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev 2003;12:4-13.
4. Van Ravesteyn NT, Schechter CB, Near AM, et al. Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev 2011;20:112-122.
5. Hewitt M, Simone JV. Ensuring quality cancer care. Washington, DC: Institute of Medicine and National Research Council; 1999.
6. Taplin SH, Yabroff KR, Zapka J. A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram. Cancer Epidemiol Biomarkers Prev 2012;21:1-7.
7. Njai R, Siegel P, Miller J, Liao Y. Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995-2006. Prev Chronic Dis 2011;8(3):A59.
8. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006;144:541-553.
9. Grabler P, Dupuy D, Rai J, Bernstein S, Ansell D. Regular screening mammography before the diagnosis of breast cancer reduces black: white breast cancer differences and modifies negative biological prognostic factors. Breast Cancer Res Treat 2012;135:549-553.
10. Olivotto I, Gomi A, Bancej C, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002;94:2143-150.
11. Taplin S, Clauser S, Rodgers A, Breslau E, Rayson D. Interfaces across the cancer continuum offer opportunities to improve the process of care. J Natl Cancer Inst Monogr 2010:104-110.
12. Jones BA, Dailey A, Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control 2005;16:809-821.
13. Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB. Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health 2010;100:1769-1776.
14. Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin Oncol 2010;37:384-401.
15. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat 2008;109:545-557.
16. Chavez-MacGregor M, Litton J, Chen H, et al. Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy. Cancer 2010;116:4168-77.
17. German RR, Fink AK, Heron M, et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol 2011;35:126-131.
18. CDC. The Guide to Community Preventive Services: increasing breast, cervical, and colorectal cancer screening. Atlanta, GA: US Department of Health and Human Services, CDC2012. Additional information available at http://www.thecommunityguide.org/index.html.
19. Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer 2011;117(15 Suppl):3539-42.
20. Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA Cancer J Clin 2012;62:217-9.